For individual and for public health, drug safety has significant implications on a large scale. Given the inherently uncertain safety and effectiveness of drugs, discussion of the significance of benefit/risk communication with stakeholders including healthcare professionals and patients has been repeated. In pharmacovigilance, risk communication has an enormous role with the object of measures for drug safety and its importance would be recognized. According to WHO Glossary of terms used in pharmacovigilance, risk is defined as the probability of harm being caused; the probability (chance, odds) of an occurrence. Risk communication is one of the composing element in risk analysis along with risk assessment and risk management in the field of food and environmental issues Risk Communication Regarding Drug Safety in Japan Michiko Yamamoto (2014).
Adverse drug reactions are negative consequences of drug therapy and can be a major setback in clinical practice. Cutaneous adverse drug reactions (CADRS) are the commonest manifestations of ADRs. Effective monitoring of CADRs forms an integral part of ADR monitoring programmes as well as pharmacovigilance Study of cutaneous adverse drug reactions in a tertiary care hospital Mohammed Yunus Khan, Prudhwi, Alekhya.
Journal of Clinical toxicology is a bimonthly journal addressing the clinical impacts and toxicological effects of drugs and drug formulations. This international journal discusses various impacts of these drugs on patients as well as in pre-clinical stages.
Last date updated on June, 2014